Moderna reported a bigger-than-expected quarterly loss on Friday, hit by a charge related to its efforts to scale down ...

Moderna swung to a loss in the last three months of the year after an early launch of its updated Covid-19 vaccine shifted sales out of the fourth quarter.

Longtime anti-vaccine critic Robert F. Kennedy was confirmed Tuesday as the new Secretary of Health and Human Services.

Moderna is set to release its fourth-quarter earnings on Friday before the opening bell. Here's a look at what to expect in ...

Data on mRNA vaccines sent by Moderna to European regulators before the COVID-19 outbreak included early tests of the mRNA ...

Vaccinations alone may not be enough to protect people with compromised immune systems from infection, even if the vaccine ...

A recent study from Temple University finds a majority of Pennsylvania college students consider themselves educated about ...

A nasal vaccine for COVID-19 – based on technology developed at Washington University in St. Louis – is poised to enter a phase 1 clinical trial in the U.S. after an investigational new drug ...

Its COVID-19 vaccine, once a nearly $38 billion a year product, brought in sales of $3.38 billion in the quarter, beating expectations by about $280 million. "Our revenue volatility is largely in ...